AZD7325 is a potent and orally active partial selective PAM of GABAAalpha2 and Aalpha3 receptor (Ki=0.3 and 1.3 nM, respectively), and has less antagonistic efficacy at the Aalpha1 and Aalpha5 receptor subtypes[1][4]. AZD7325 is a moderate CYP1A2 and a potent CYP3A4 inducer in vitro[2]. AZD7325 has the potential for the investigation of anxiety and dravet syndrome[3]. PAM: positive allosteric modulator.
Molecular Weight:
354.38
Purity:
99.95
CAS Number:
[942437-37-8]
Formula:
C19H19FN4O2
Target:
Cytochrome P450,GABA Receptor
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
